Genky DrugStores Co., Ltd. provided consolidated earnings guidance for the first half and full year of fiscal year ending June 20, 2024. For the first half, the company expects net sales of JPY 89,500 million, operating income of JPY 3,450 million, net income attributable to owners of parent of JPY 2,340 million and net income per share of JPY 154.11.

For the full year, the company expects net sales of JPY 180,000 million, operating income of JPY 7,000 million, net income attributable to owners of parent of JPY 4,900 million and net income per share of JPY 322.71.